Literature DB >> 7057619

Effect of carnitine on serum HDL-cholesterol: report of two cases.

C S Rossi, N Siliprandi.   

Abstract

In two otherwise normal male subjects selected for normal serum cholesterol and triglycerides but low serum high-density lipoprotein (HDL) levels, oral administration of 1 g per day of L-carnitine over a period of 10-15 weeks caused a substantial increase in high-density lipoprotein levels, as well as a decrease in serum triglycerides. The ratio of HDL-cholesterol to total cholesterol increased, but this change was not due to an obligatory lowering of total cholesterol. Possible mechanisms of the carnitine effect are discussed. Since elevated high-density lipoprotein levels significantly reduce the risk of arteriosclerotic cardiovascular disease, this action of carnitine deserves further study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057619

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


  2 in total

1.  Serum levels of carnitine, apolipoprotein A I, and apolipoprotein B in children with nephrotic proteinuria.

Authors:  Z Bircan; A Kaplan; M Söker; S Batun; A Sahin; M Soran
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

Review 2.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.